Your browser doesn't support javascript.
loading
Nanodrugs for the Treatment of Ischemic Stroke: A Systematic Review.
Ruscu, Mihai; Cercel, Andreea; Kilic, Ertugrul; Catalin, Bogdan; Gresita, Andrei; Hermann, Dirk M; Albu, Carmen Valeria; Popa-Wagner, Aurel.
Afiliação
  • Ruscu M; Doctoral School, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
  • Cercel A; Doctoral School, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
  • Kilic E; Department of Physiology, School of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.
  • Catalin B; Doctoral School, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
  • Gresita A; Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY 115680-8000, USA.
  • Hermann DM; Doctoral School, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
  • Albu CV; Department of Neurology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
  • Popa-Wagner A; Department of Neurology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
Int J Mol Sci ; 24(13)2023 Jun 28.
Article em En | MEDLINE | ID: mdl-37445979
ABSTRACT
Ischemic stroke, a significant neurovascular disorder, currently lacks effective restorative medication. However, recently developed nanomedicines bring renewed promise for alleviating ischemia's effects and facilitating the healing of neurological and physical functions. The aim of this systematic review was to evaluate the efficacy of nanotherapies in animal models of stroke and their potential impact on future stroke therapies. We also assessed the scientific quality of current research focused on nanoparticle-based treatments for ischemic stroke in animal models. We summarized the effectiveness of nanotherapies in these models, considering multiple factors such as their anti-inflammatory, antioxidant, and angiogenetic properties, as well as their safety and biodistribution. We conclude that the application of nanomedicines may reduce infarct size and improve neurological function post-stroke without causing significant organ toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Nanopartículas / AVC Isquêmico Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Nanopartículas / AVC Isquêmico Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article